News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
In a reversal from three years ago, the Court of Justice of the European Union (CJEU) ruled on Thursday that an organism incapable of developing into a human being is not a human embryo and may be patented.
Korean and Harvard University scientists have developed a way to non–surgically inject programmable biomaterial to deliver a 3D vaccine that can more effectively treat diseases like cancer or HIV.
Kymab has received a grant from the UK’s Wellcome Trust to develop treatments against Ebola using its human antibody discovery platform, Kymouse.